• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Latest News about FLHLF

    Recent news which mentions FLHLF

    < Previous 1 2 Next >
    Supply Partnerships: Filament's Psilocybin Trial In Canada, PharmAla's MDMA Program In Australia
    Tickers FLHLF
    Tags Management Contracts Psilocybin program
    From Benzinga
    EXCLUSIVE: Defining 'Natural' Psychedelics, State Regulations & Ayahuasca's Benefits
    Tickers DMT FLHLF
    Tags Ayahuasca Global Market News
    From Benzinga
    Psyched: States With Psychedelics Legalization Bills, Next-Gen Molecule For Addiction Treatment And More
    Tickers CLABF CMND CYBN FLHLF
    Tags Legal Market News Psychedelics Investing
    From Benzinga
    Psychiatry And Business Collaborate: European Psychedelics Trial Tackles Alcohol Addiction
    Tickers FLHLF
    Tags Psychiatric Centre Copenhagen Psilocybin program Psychedelics
    From Benzinga
    6 Psychedelics Companies Take Action: Here Are The Latest, Major Announcements
    Tickers BRAXF FLHLF HUGE IWINF
    Tags Psychedelic/Assisted Therapies IWINF Penny Stocks
    From Benzinga
    Psyched: First Ayahuasca Pill Created, Psychedelics Legalization Predicted, UK's Research Support And More
    Tickers AWKNF CMND FLHLF MYCOF
    Tags Psychedelics Investing AWKNF PSYK
    From Benzinga
    EXCLUSIVE: The Psychedelics Debate Is 'Raging' As Filament Debuts Ayahuasca Pill
    Tickers CMPS FLHLF
    Tags Exclusives Markets Interview
    From Benzinga
    Psychedelics Company Filament Signs Licensing Deal With Psyence In US, UK And EU
    Tickers FLHLF PSYGF
    Tags Market News Offerings Contracts
    From Benzinga
    EXCLUSIVE: Ayahuasca Pill Is Officially Here, Filament CEO Discusses Future Plans
    Tickers AGNPF ATAI FLHLF
    Tags Ayahuasca Market News Exclusives
    From Benzinga
    Psyched: Fed Guidelines And Research Production Quotas, Protests In Canada, Cal's Decrim Project
    Tickers AWKNF BRAXF DEA FLHLF
    Tags NUMIF XTXXF Psychedelic Research
    From Benzinga
    Natural Psychedelics Extraction & Standardization Obtains Two New US Patents
    Tickers FLHLF
    Tags Economics of Psychedelics Investing Market News Legal
    From Benzinga
    Psyched: Colorado Legalizes Psychedelics, NYC Treats Alcoholism With Ketamine, $30M Series A For Startup
    Tickers ATAI AWKNF BLRZF FLHLF
    Tags Markets MNMD Small Cap
    From Benzinga
    Filament Health Shares Q3 2022 Results, On Road To Becoming Industry's Natural Psilocybin Supplier
    Tickers FLHLF
    Tags Management Psychedelics FLHLF
    From Benzinga
    Psyched: Brock Pierce Joins Psychedelic VC, Colorado's Psychedelics Legalization, Zappy Zapolin's Open Letter & More
    Tickers ATAI FLHLF PSIL PSYK
    Tags Mystic Ventures Psychedelics Investing PSYK
    From Benzinga
    EXCLUSIVE: Crypto Billionaire Brock Pierce Joins Psychedelic Venture Fund, Says 'Potential Reward Is Immeasurable'
    Tickers ATAI FLHLF
    Tags Market News USDT $USDT
    From Benzinga
    Filament Begins First Ever FDA-Approved Clinical Trial On Naturally-Derived Psychedelic Drugs
    Tickers FLHLF
    Tags Psychedelics Legal FLHLF
    From Benzinga
    Canadian Special Access Program Further Authorizes Novel Psychedelic Drugs For Emergency Treatments
    Tickers BRAXF FLHLF
    Tags Apex Labs Global General
    From Benzinga
    Psyched: Elon Musk Tweets About Psychedelics, Numinus Acquires Novamind, Colorado Gov. Signs MDMA Legalization Bill
    Tickers CYBN ENTBF FLHLF JAGX
    Tags OPTHF MSSTF TWTR
    From Benzinga
    Two Psychedelics Drug Development Companies Work To Produce Novel Plant-Based Compounds For Mental Health Disorders
    Tickers FLHLF JAGX
    Tags Cannabis Entheogen Therapeutics Initiative FLHLF
    From Benzinga
    Optimi Health Signs Two New Supply Agreements In Less Than a Week
    Tickers CPH FLHLF OPTHF
    Tags OPTHF Bill Ciprick Market News
    From Benzinga
    Patents In The Psychedelics Space: Good Or Bad? It's Complicated, Here's What The Experts Say
    Tickers CMPS FLHLF
    Tags General Compass Pathways Market News
    From Benzinga
    Filament Health Keeps Adding Patents To Its Portfolio, Just Received Its Fourth
    Tickers FLHLF
    Tags Psychedelics FLHLF Market News
    From Benzinga
    Psyched: Big Pharma's Sanofi Enters Psychedelics Space, DNA From 80 Psilocybe Mushrooms Published Online, Maine Psychedelics Bill Shelved
    Tickers ATAI CMPS CYBN ENVB
    Tags PCC NMDBF Market News
    From Benzinga
    Filament Health Talks Psilocybins, Psilocins And How Natural Psychedelics Could Conquer The Market
    Tickers FLHLF
    Tags Market News FLHLF Partner Content
    From Benzinga
    Psyence, Filament Strike Magic Mushroom Product Licensing Agreement: What You Need To Know
    Tickers FLHLF PSYGF
    Tags Psyence Group Market News Filament Health Corp/
    From Benzinga
    Filament Health Acquires Patent For Extracting And Standardizing Natural Psilocybin
    Tickers FLHLF
    Tags Psilo Scientific Psychedelics FLHLF
    From Benzinga
    Psyched: Psychedelics ETF Launches On NYSE, Psilocybin Trial Approved For Depression, DMT Study Begins
    Tickers CYBN ENTBF FLHLF NUMIF
    Tags CYBN psychedelics FLHLF
    From Benzinga
    Magic Mushrooms For Depression: Clinical Trial Of Active Compound Approved For Patients Using Antidepressants
    Tickers CYBN FLHLF
    Tags Markets Penny Stocks Benzinga
    From Benzinga
    Psychedelic Stock Gainers And Losers From January 17, 2022
    Tickers ALID ATAI AWKNF CMPS
    Tags CYBN CMPS BZI/PSYCH
    From Benzinga
    Psyched: Canada's Access To Psychedelic Medicines, Psilocybin No Cognitive Side Effects, Psilocybin Bill Washington
    Tickers CMPS FLHLF MNMD
    Tags Penny Stocks Benzinga Small Cap
    From Benzinga
    < Previous 1 2 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.